וימפט 10 מגמל ישראל - עברית - Ministry of Health

וימפט 10 מגמל

neopharm ltd, israel - lacosamide - תמיסה לאינפוזיה - lacosamide 10 mg / 1 ml - lacosamide

ביקמיד 150 מ"ג ישראל - עברית - Ministry of Health

ביקמיד 150 מ"ג

taro international ltd - bicalutamide 150 mg - film coated tablets - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0) bicamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.

מדימיד 50 מ"ג ישראל - עברית - Ministry of Health

מדימיד 50 מ"ג

medison pharma ltd - bicalutamide 50 mg - film coated tablets - bicalutamide - treatment of advanced prostate cancer in combination with lhrh analogues or surgical castration.

אלבסקו 40 ישראל - עברית - Ministry of Health

אלבסקו 40

agis commercial agency (1989) - ciclesonide 40 mcg - solution for inhalation - ciclesonide - treatment to control persistent asthma in adults and adolescents ( 12 years and older) .

אלבסקו 80 ישראל - עברית - Ministry of Health

אלבסקו 80

agis commercial agency (1989) - ciclesonide 80 mcg - solution for inhalation - ciclesonide - treatment to control persistent asthma in adults and adolescents ( 12 years and older) .

אלבסקו 160 ישראל - עברית - Ministry of Health

אלבסקו 160

agis commercial agency (1989) - ciclesonide 160 mcg - solution for inhalation - ciclesonide - treatment to control persistent asthma in adults and adolescents ( 12 years and older) .

וימפט 10 מ"ג/מ"ל ישראל - עברית - Ministry of Health

וימפט 10 מ"ג/מ"ל

cts ltd - lacosamide 10 mg / 1 ml - solution for infusion - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.vimpat solution for infusion is an alternative for patients when oral administration is temporary not feasible.

אינטלנס 100 מג ישראל - עברית - Ministry of Health

אינטלנס 100 מג

j-c health care ltd - etravirine - טבליה - etravirine 100 mg - etravirine - etravirine - intelence is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-experienced adult patients including those with non-nucleoside reverse transcriptase inhibitor (nnrti) resistance. treatment history and when available resistance testing should guide the use of intelence. in patients who have experienced virological failure on an nnrti- and nucleoside or nucleotide reverse transcriptase inhibitor (n[t]rti) - containing regimen intelence is not recommended for use in combination with n(t)rtis only.

אינטלנס 200 מג ישראל - עברית - Ministry of Health

אינטלנס 200 מג

j-c health care ltd - etravirine - טבליה - etravirine 200 mg - etravirine - etravirine - intelence is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-experienced adult patients including those with non-nucleoside reverse transcriptase inhibitor (nnrti) resistance. treatment history and when available resistance testing should guide the use of intelence. in patients who have experienced virological failure on an nnrti- and nucleoside or nucleotide reverse transcriptase inhibitor (n[t]rti)- containing regimen intelence is not recommended for use in combination with n(t)rtis only.

יונדליס 1 מג ישראל - עברית - Ministry of Health

יונדליס 1 מג

megapharm ltd - trabectedin - concentrate for solution for infusion - trabectedin 1 mg/vial - trabectedin - trabectedin - yondelis is indicated for the treatment of patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents. efficacy data are based mainly on liposarcoma and leiomyosarcoma patients.